Gencurix Publishes a Clinical Validation Study on GenesWell BCT, a New Breast Cancer Prognostic Test
SEOUL, South Korea--(BUSINESS WIRE)--On 28 March, Gencurix (KONEX:229000) announced that the results of clinical trials for the prediction of breast cancer prognosis were published in Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback